医学临床研究
  2025年4月6日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2019, Vol. 36 Issue (2): 265-270    DOI: 10.3969/j.issn.1671-7171.2019.02.017
  论著 本期目录 | 过刊浏览 | 高级检索 |
斑蝥酸钠维生素B6注射液联合TP方案化疗对晚期NSCLC的疗效及相关指标的影响
王大中
中国医科大学肿瘤医院暨辽宁省肿瘤医院胸内三科,辽宁 沈阳 110042
Efficacy of Sodium Cantharidin Combined with TP Themotherapy on Advanced Non-small Cell Lung Cancer and Influence on Tumor Angiogenesis
WANG Da-zhong
China Medical University Oncology Hospital and Liaoning Provincial Oncology Hospital,Shenyang 110042
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨斑蝥酸钠维生素B6注射液联合紫杉醇与顺铂联合化疗方案(TP)化疗对晚期非小细胞肺癌(NSCLC)的疗效及对肿瘤标志物和血管新生指标的影响。方法 本院收治的晚期NSCLC患者76例,随机分为两组,各38例。对照组患者接受TP化疗,观察组接受斑蝥酸钠维生素B6注射液联合TP化疗,均完成两疗程治疗。比较两组近期疗效及血清肿瘤标志物、血管新生指标含量的差异。结果 治疗后,观察组患者的有效率(RR)、疾病控制率(DCR)均高于对照组(P<0.05),且血清中肿瘤标志物细胞角蛋白19片段(Cyfra21-1)、癌胚抗原(CEA)、糖类抗原125(CA125)含量及血管新生指标血管内皮生长因子(VEGF)、细胞血管生成素-2(Ang-2)、基质金属蛋白酶-9(MMP-9)的含量均低于对照组(P<0.05)。结论 斑蝥酸钠维生素B6注射液联合TP化疗可提升晚期NSCLC患者的治疗效果,降低肿瘤血管新生活性。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
王大中
关键词 非小细胞肺/药物疗法顺铂/治疗应用    
AbstractObjective To investigate the therapeutic effect of sodium cantharidate vitamin B6 combined with paclitaxel and cisplatin chemotherapy (TP) on advanced non-small cell lung cancer (NSCLC) and its influence on tumor markers and angiogenesis.Methods A total of 76 cases of advanced NSCLC patients was randomly divided into two group (n=38) . Patients in the control group were treated with TP chemotherapy only while those in the observation group were treated with sodium cantharidin combined with TP chemotherapy. Patients in both groups completed 2 courses of treatment. The short-term efficacy, serum contents of tumor markers and angiogenesis markers were compared between two groups. Results After 2 courses of treatment, the effective rate (RR) and disease control rate (DCR) in the observation group were higher than those in the control group (P<0.05) and the serum tumor markers Cyfra21-1, (CEA), carbohydrate antigen125 (CA125) and angiogenesis indicators of vascular endothelial growth factor (VEGF), angiopoietin-2 (Ang-2), matrix metalloproteinase-9 were lower than the control group (P<0.05). Conclusion Sodium hyaluronate vitamin 6 combined with TP chemotherapy can improve the treatment effect in patients with advanced NSCLC and reduce angiogenesis activity.
Key wordsCarcinoma    Non-Small-Cell Lung/ DT    Cisplatin/TU
收稿日期: 2018-03-27     
PACS:  R730.26  
引用本文:   
王大中. 斑蝥酸钠维生素B6注射液联合TP方案化疗对晚期NSCLC的疗效及相关指标的影响[J]. 医学临床研究, 2019, 36(2): 265-270.
WANG Da-zhong. Efficacy of Sodium Cantharidin Combined with TP Themotherapy on Advanced Non-small Cell Lung Cancer and Influence on Tumor Angiogenesis. JOURNAL OF CLINICAL RESEARCH, 2019, 36(2): 265-270.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2019.02.017     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2019/V36/I2/265
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn